Do analysts rate INBS or BEAT?

HeartBeam has a consensus price target of $4.00, indicating a potential upside of 928.54%. Given HeartBeam's stronger consensus rating and higher probable upside, analysts clearly believe HeartBeam is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 HeartBeam 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.56

Do analysts recommend INBS or FEMY?

Femasys has a consensus target price of $50.00, indicating a potential upside of 1,837.98%. Given Femasys' stronger consensus rating and higher probable upside, analysts plainly believe Femasys is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Do analysts recommend MODD or INBS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts recommend INBS or LFWD?

Lifeward has a consensus price target of $10.00, suggesting a potential upside of 41.34%. Given Lifeward's stronger consensus rating and higher possible upside, analysts plainly believe Lifeward is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Lifeward 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts rate CTSO or INBS?

Cytosorbents currently has a consensus price target of $107.50, indicating a potential upside of 2,089.41%. Given Cytosorbents' stronger consensus rating and higher probable upside, analysts plainly believe Cytosorbents is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cytosorbents 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Intelligent Bio Solutions (INBS) Competitors

$1.77 -0.03 (-1.67%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$1.84 +0.06 (+3.67%)

As of 04:58 AM Eastern

Compare

INBS vs. BEAT, FEMY, MODD, LFWD, and CTSO

Should you buy Intelligent Bio Solutions stock or one of its competitors? Intelligent Bio Solutions's main competitors and comparable companies include HeartBeam (BEAT), Femasys (FEMY), Modular Medical (MODD), Lifeward (LFWD), and Cytosorbents (CTSO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Intelligent Bio Solutions compare to HeartBeam?

Intelligent Bio Solutions (NASDAQ:INBS) and HeartBeam (NASDAQ:BEAT) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

HeartBeam has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -294.88%. Intelligent Bio Solutions' return on equity of -175.35% beat HeartBeam's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%
HeartBeam	N/A	-686.78%	-348.65%

Intelligent Bio Solutions has higher revenue and earnings than HeartBeam. HeartBeam is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$4.22M	1.39	-$12.43M	-$9.02	N/A
HeartBeam	N/A	N/A	-$21.01M	-$0.51	N/A

In the previous week, HeartBeam had 4 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 4 mentions for HeartBeam and 0 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 0.00 beat HeartBeam's score of -0.67 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Intelligent Bio Solutions	Neutral
HeartBeam	Negative

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 7.8% of HeartBeam shares are held by institutional investors. 1.3% of Intelligent Bio Solutions shares are held by insiders. Comparatively, 18.0% of HeartBeam shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Intelligent Bio Solutions has a beta of 4.25, meaning that its stock price is 325% more volatile than the broader market. Comparatively, HeartBeam has a beta of -0.8, meaning that its stock price is 180% less volatile than the broader market.

HeartBeam has a consensus price target of $4.00, indicating a potential upside of 928.54%. Given HeartBeam's stronger consensus rating and higher probable upside, analysts clearly believe HeartBeam is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
HeartBeam	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56

Summary

Intelligent Bio Solutions and HeartBeam tied by winning 8 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Femasys?

Intelligent Bio Solutions (NASDAQ:INBS) and Femasys (NASDAQ:FEMY) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

In the previous week, Femasys had 1 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 1 mentions for Femasys and 0 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 0.00 equaled Femasys'average media sentiment score.

Company	Overall Sentiment
Intelligent Bio Solutions	Neutral
Femasys	Neutral

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 65.3% of Femasys shares are held by institutional investors. 1.3% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 7.8% of Femasys shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Intelligent Bio Solutions has a beta of 4.25, meaning that its share price is 325% more volatile than the broader market. Comparatively, Femasys has a beta of -2.07, meaning that its share price is 307% less volatile than the broader market.

Femasys has a consensus target price of $50.00, indicating a potential upside of 1,837.98%. Given Femasys' stronger consensus rating and higher probable upside, analysts plainly believe Femasys is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Intelligent Bio Solutions has a net margin of -294.88% compared to Femasys' net margin of -534.36%. Intelligent Bio Solutions' return on equity of -175.35% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%
Femasys	-534.36%	-225.97%	-74.68%

Intelligent Bio Solutions has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$4.22M	1.39	-$12.43M	-$9.02	N/A
Femasys	$2.29M	9.44	-$18.63M	-$3.53	N/A

Summary

Femasys beats Intelligent Bio Solutions on 9 of the 15 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Modular Medical?

Modular Medical (NASDAQ:MODD) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

Intelligent Bio Solutions has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A
Intelligent Bio Solutions	$4.22M	1.39	-$12.43M	-$9.02	N/A

Modular Medical has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.25, meaning that its stock price is 325% more volatile than the broader market.

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Modular Medical has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -294.88%. Intelligent Bio Solutions' return on equity of -175.35% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-292.14%	-222.79%
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%

In the previous week, Modular Medical had 1 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 1 mentions for Modular Medical and 0 mentions for Intelligent Bio Solutions. Modular Medical's average media sentiment score of 0.67 beat Intelligent Bio Solutions' score of 0.00 indicating that Modular Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Modular Medical	Positive
Intelligent Bio Solutions	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Intelligent Bio Solutions beats Modular Medical on 8 of the 13 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Lifeward?

Intelligent Bio Solutions (NASDAQ:INBS) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

Lifeward has a consensus price target of $10.00, suggesting a potential upside of 41.34%. Given Lifeward's stronger consensus rating and higher possible upside, analysts plainly believe Lifeward is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Intelligent Bio Solutions has a beta of 4.25, suggesting that its stock price is 325% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.39, suggesting that its stock price is 61% less volatile than the broader market.

Intelligent Bio Solutions has higher earnings, but lower revenue than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$4.22M	1.39	-$12.43M	-$9.02	N/A
Lifeward	$22.03M	0.91	-$19.91M	-$16.82	N/A

Lifeward has a net margin of -141.28% compared to Intelligent Bio Solutions' net margin of -294.88%. Intelligent Bio Solutions' return on equity of -175.35% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%
Lifeward	-141.28%	-235.86%	-81.72%

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 26.8% of Lifeward shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Comparatively, 1.5% of Lifeward shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Intelligent Bio Solutions' average media sentiment score of 0.00 equaled Lifeward'saverage media sentiment score.

Company	Overall Sentiment
Intelligent Bio Solutions	Neutral
Lifeward	Neutral

Summary

Intelligent Bio Solutions and Lifeward tied by winning 7 of the 14 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Cytosorbents?

Cytosorbents (NASDAQ:CTSO) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

Cytosorbents has higher revenue and earnings than Intelligent Bio Solutions. Cytosorbents is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytosorbents	$37.06M	0.42	-$8.20M	-$5.80	N/A
Intelligent Bio Solutions	$4.22M	1.39	-$12.43M	-$9.02	N/A

Cytosorbents has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.25, suggesting that its share price is 325% more volatile than the broader market.

Cytosorbents has a net margin of -48.94% compared to Intelligent Bio Solutions' net margin of -294.88%. Intelligent Bio Solutions' return on equity of -175.35% beat Cytosorbents' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytosorbents	-48.94%	-431.65%	-41.94%
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%

In the previous week, Cytosorbents had 2 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 2 mentions for Cytosorbents and 0 mentions for Intelligent Bio Solutions. Cytosorbents' average media sentiment score of 0.58 beat Intelligent Bio Solutions' score of 0.00 indicating that Cytosorbents is being referred to more favorably in the media.

Company	Overall Sentiment
Cytosorbents	Positive
Intelligent Bio Solutions	Neutral

Cytosorbents currently has a consensus price target of $107.50, indicating a potential upside of 2,089.41%. Given Cytosorbents' stronger consensus rating and higher probable upside, analysts plainly believe Cytosorbents is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

32.9% of Cytosorbents shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 7.8% of Cytosorbents shares are held by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Cytosorbents beats Intelligent Bio Solutions on 11 of the 16 factors compared between the two stocks.

Get Intelligent Bio Solutions News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INBS vs. The Competition

Export

Metric	Intelligent Bio Solutions	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.97M	$5.58B	$7.31B	$13.29B
Dividend Yield	N/A	1.79%	2.52%	12.57%
P/E Ratio	-0.20	25.26	274.07	25.69
Price / Sales	1.39	71.57	643.13	79.17
Price / Cash	N/A	33.02	77.80	52.76
Price / Book	0.80	5.78	10.47	6.32
Net Income	-$12.43M	$151.55M	$3.49B	$359.73M
7 Day Performance	-11.50%	0.01%	-0.67%	0.17%
1 Month Performance	-29.20%	-3.51%	-3.17%	-3.27%
1 Year Performance	-86.99%	6.37%	15.13%	5.58%

Intelligent Bio Solutions Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INBS Intelligent Bio Solutions	1.2853 of 5 stars	$1.77 -1.7%	N/A	-86.6%	$5.97M	$4.22M	N/A	10
BEAT HeartBeam	3.0914 of 5 stars	$0.43 +4.7%	$4.00 +841.2%	-76.1%	$22.87M	N/A	N/A	1,700	News Coverage Analyst Downgrade Gap Down High Trading Volume
FEMY Femasys	2.8055 of 5 stars	$2.56 -4.1%	$50.00 +1,853.1%	-62.5%	$22.36M	$2.29M	N/A	30	News Coverage
MODD Modular Medical	1.1429 of 5 stars	$2.41 -6.6%	N/A	-89.7%	$21.03M	N/A	N/A	20	Analyst Forecast
LFWD Lifeward	1.9668 of 5 stars	$7.07 -0.6%	$10.00 +41.4%	-13.7%	$20.14M	$22.03M	N/A	60	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INBS) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intelligent Bio Solutions (INBS) Competitors

INBS vs. BEAT, FEMY, MODD, LFWD, and CTSO

How does Intelligent Bio Solutions compare to HeartBeam?

Summary

How does Intelligent Bio Solutions compare to Femasys?

Summary

How does Intelligent Bio Solutions compare to Modular Medical?

Summary

How does Intelligent Bio Solutions compare to Lifeward?

Summary

How does Intelligent Bio Solutions compare to Cytosorbents?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Intelligent Bio Solutions (INBS) Competitors

INBS vs. BEAT, FEMY, MODD, LFWD, and CTSO

How does Intelligent Bio Solutions compare to HeartBeam?

Is INBS or BEAT more profitable?

Which has better earnings and valuation, INBS or BEAT?

Does the media prefer INBS or BEAT?

Do institutionals and insiders hold more shares of INBS or BEAT?

Which has more volatility & risk, INBS or BEAT?

Do analysts rate INBS or BEAT?

Summary

How does Intelligent Bio Solutions compare to Femasys?

Does the media prefer INBS or FEMY?

Do insiders and institutionals hold more shares of INBS or FEMY?

Which has more volatility and risk, INBS or FEMY?

Do analysts recommend INBS or FEMY?

Is INBS or FEMY more profitable?

Which has higher valuation and earnings, INBS or FEMY?

Summary

How does Intelligent Bio Solutions compare to Modular Medical?

Which has stronger valuation & earnings, MODD or INBS?

Which has more volatility & risk, MODD or INBS?

Do institutionals and insiders believe in MODD or INBS?

Is MODD or INBS more profitable?

Does the media prefer MODD or INBS?

Do analysts recommend MODD or INBS?

Summary

How does Intelligent Bio Solutions compare to Lifeward?

Do analysts recommend INBS or LFWD?

Which has more risk & volatility, INBS or LFWD?

Which has better valuation and earnings, INBS or LFWD?

Is INBS or LFWD more profitable?

Do institutionals and insiders hold more shares of INBS or LFWD?

Does the media refer more to INBS or LFWD?

Summary

How does Intelligent Bio Solutions compare to Cytosorbents?

Which has stronger valuation and earnings, CTSO or INBS?

Which has more volatility & risk, CTSO or INBS?

Is CTSO or INBS more profitable?

Does the media prefer CTSO or INBS?

Do analysts rate CTSO or INBS?

Do insiders & institutionals hold more shares of CTSO or INBS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools